Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
AJ Grossberg, LC Chu, CR Deig… - CA: a cancer journal …, 2020 - Wiley Online Library
Despite tremendous gains in the molecular understanding of exocrine pancreatic cancer,
the prognosis for this disease remains very poor, largely because of delayed disease …
the prognosis for this disease remains very poor, largely because of delayed disease …
Early detection of pancreatic cancer
Pancreatic ductal adenocarcinoma is most frequently detected at an advanced stage. Such
late detection restricts treatment options and contributes to a dismal 5-year survival rate of 3 …
late detection restricts treatment options and contributes to a dismal 5-year survival rate of 3 …
European evidence-based guidelines on pancreatic cystic neoplasms
European Study Group on Cystic Tumours of the … - Gut, 2018 - gut.bmj.com
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …
[HTML][HTML] Early detection of pancreatic cancer: opportunities and challenges
Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic,
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
M Tanaka, C Fernández-del Castillo, T Kamisawa… - Pancreatology, 2017 - Elsevier
The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …
particular, the indications for resection of branch duct IPMN have changed from early …
Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance
Background & Aims Screening of individuals who have a high risk of pancreatic ductal
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …
Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer
M Kitano, T Yoshida, M Itonaga, T Tamura… - Journal of …, 2019 - Springer
Accumulated evidence has revealed that endoscopic ultrasonography (EUS) has had a
great impact on the clinical evaluation of pancreatic cancers. EUS can provide high …
great impact on the clinical evaluation of pancreatic cancers. EUS can provide high …
Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms
H Oyama, M Tada, K Takagi, K Tateishi, T Hamada… - Gastroenterology, 2020 - Elsevier
Background & Aims Long-term outcomes of patients with branch-duct intraductal papillary
mucinous neoplasms (IPMNs), particularly those after 5 years of surveillance, have not been …
mucinous neoplasms (IPMNs), particularly those after 5 years of surveillance, have not been …
Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression
Purpose: Early detection of pancreatic ductal adenocarcinoma (PDAC) remains elusive.
Precursor lesions of PDAC, specifically intraductal papillary mucinous neoplasms (IPMNs) …
Precursor lesions of PDAC, specifically intraductal papillary mucinous neoplasms (IPMNs) …
Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia
Objective DNA-based testing of pancreatic cyst fluid (PCF) is a useful adjunct to the
evaluation of pancreatic cysts (PCs). Mutations in KRAS/GNAS are highly specific for …
evaluation of pancreatic cysts (PCs). Mutations in KRAS/GNAS are highly specific for …